Table 2.
Health care resource utilization during 1 year of postindex follow-up among patients with focal segmental glomerulosclerosis with and without nephrotic range proteinuria
| Variable | Nephrotic range (n = 112) | Non-nephrotic (n = 196) | P value |
|---|---|---|---|
| Outpatient office visits | |||
| Patients with visits | 112 (100) | 196 (100) | — |
| Number of visits | 14.6 ± 8.7 | 10.0 ± 7.7 | <0.0001 |
| Emergency department visits | |||
| Patients with visits | 56 (50.0) | 70 (35.7) | 0.0142 |
| Number of visits | 1.5 ± 4.1 | 0.7 ± 1.3 | 0.0476 |
| Inpatient stays | |||
| Patients with stays, n (%) | 44 (39.3) | 41 (20.9) | 0.0005 |
| Length of stay, mean ± SD | 5.7 ± 4.5 | 5.9 ± 4.0 | 0.7930 |
| Prescriptions | |||
| Patients with prescriptions, n (%) | 109 (97.3) | 187 (95.4) | 0.4039 |
| Number of prescriptions, mean ± SD | 49.0 ± 32.5 | 39.7 ± 31.5 | 0.0141 |
| FSGS medication prescriptions, n (%) | 0.0106 | ||
| No disease-modifying drugs | 30 (26.8) | 90 (45.9) | |
| Glucocorticoids only | 52 (46.4) | 65 (33.2) | |
| Glucocorticoids + other disease-modifying drugs | 23 (20.5) | 33 (16.8) | |
| Nonglucocorticoids | 7 (6.3) | 8 (4.1) | |
| Any glucocorticoid, n (%) | 75 (67.0) | 98 (50.0) | 0.0039 |
FSGS, focal segmental glomerulosclerosis.
Continuous variables are expressed as mean ± SD, and categorical variables as n and (%).